Naval Health Clinic New England (NHCNE) was formally recognized for its significant contributions to the Department of Defense Global Respiratory Surveillance Program (DoDGRSP) during the 2025–26 respiratory season. Naval Health Clinic New England Recognized for Support to DoD Global Respiratory Surveillance…
WEST Yorkshire is among the highest spenders on NHS prescriptions. A new study by Cured Pharmacy found that the West Yorkshire Integrated Care Board (ICB) spends £292.42 per person on prescriptions, the third-highest rate in England. The area recorded the largest…
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the CHEST 2026 Annual Meeting in Phoenix, Arizona. The... -- Post-Hoc Analysis of the Phase 2/3 IMPALA Clinical Trial Presented in a Poster…
LVPG Pulmonology offers minimally invasive lung valve procedure A treatment now being offered by LVPG Pulmonology and Critical Care Medicine provides new relief for patients with chronic obstructive pulmonary disease (COPD), including severe emphysema. Bronchoscopic lung volume reduction, or BLVR,…
12 SECTIONS · TAP TO OPEN Triple Inhalers in COPD: Mortality Findings, No Label Claim Class Mechanism of Action Approved Agents and Indications Boxed Warnings and REMS Generated October 2026 · Clinical Deep Dive For the clinician deciding whether and how to escalate, the…
One of the specialties our pediatric surgeons are trained in is procedures specific to the airway and pulmonary tract (the lungs). These can include treatment of lung malformations and tumors or airway obstructions and congenital abnormalities. We treat the following…
Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary (lung) disease in humans. Pulmonary NTM is on the rise in the United States, according to a large study of people hospitalized with…
Smoking is a leading cause of COPD, but people who have never smoked can also have it. Long-term exposure to dust, fumes, or air pollution can contribute, and genetics also raises the risk. While there is no cure for COPD,…
– Rademikibart significantly reduced the rate of treatment failure compared to placebo through one month by 81% (p=0.0122) – – Rademikibart significantly reduced the rate of new moderate to severe COPD exacerbations through one month by 85% (p=0.030) – – Rademikibart significantly reduced the rate of hospitalizations or emergency…
“This new COPD diagnostic schema, which includes chest imaging, respiratory symptoms and spirometry, identified additional individuals at risk of poor respiratory outcomes,” said Bhatt, a professor in the Department of Medicine at the University of Alabama at Birmingham Marnix E.
Chronic obstructive pulmonary disease and emphysema: inhalers, new biologic treatments, oxygen, rehabilitation and living with COPD.
An article joins this feed when it matches these terms. Each one is also a search of its own.